Factors affecting quality of life of asthma patients in Spain: The importance of patient education
Autors de IIS La Fe
Autors aliens a IIS La Fe
- Martinez-Moragon, E
- Palop, M
- Serra, J
- Pellicere, C
- Casan, P
- Caloto, MT
- Nocea, G
- ASMACOST Study Grp
Grups d'Investigació
Abstract
Objectives: Assessment of demographic and clinical factors that have an impact on the quality of life (QoL) of patients with asthma in Spain. Patients and methods: Multicenter, prospective, observational, cohort study, conducted in 40 Spanish Pneumology Units during a 12-month period. Data on sociodemographic, clinical variables, asthma treatment and QoL were collected in a case report form. Results: 536 patients (64.6% women, mean age: 54) were recruited. Reported QoL was better for patients from Northern and Central Spain as compared with those from the South and the East (p < 0.001), students and employed patients as compared with housewives and unemployed (p < 0.01), for those who had received asthma information (p < 0.01), for those with milder daytime symptoms (p < 0.01) and for patients with higher level of education (p < 0.05). Conclusions: Among the factors that have a significant effect on patients' QoL only symptom control and patient education on asthma control are modifiable. Therefore, all the strategies should be tailored to improve such factors when managing asthma patients. (C) 2013 SEICAP. Published by Elsevier Espana, S.L.U. All rights reserved.
Dades de la publicació
- ISSN/ISSNe:
- 0301-0546, 1578-1267
- Tipus:
- Article
- Pàgines:
- 476-484
- PubMed:
- 24094444
- Factor d'Impacte:
- 0,434 SCImago ℠
- Quartil:
- Q2 SCImago ℠
ALLERGOLOGIA ET IMMUNOPATHOLOGIA ELSEVIER DOYMA SL
Cites Rebudes en Web of Science: 5
Documents
- No hi ha documents
Filiacions
Keywords
- Quality of life; Asthma; Education
Projectes associats
SAS115359, UN ESTUDIO DE SEGURIDAD Y EFICACIA DE UNA COMBINACIÓN DE PROPIONATO DE FLUTICASONA/SALMETEROL INHALADA FRENTE A PROPIONATO DE FLUTICASONA INHALADO EN EL TRATAMIENTO DE SUJETOS ADOLESCENTES Y ADULTOS CON ASMA.
Investigador Principal: ANTONIO NIETO GARCÍA
SAS115359 . 2012
ENSAYO FASE III, MULTICENTRICO, ALEATORIZADO, DOBLE CIEGO, CON GRUPOS PARALELOS, CONTROLADO CON PLACEBO, DE 52 SEMANAS, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE TRALOKINUMAB EN ADULTOS Y ADOLESCENTES CON ASMA INSUFICIENTEMENTE CONTROLADA CON CORTICOSTEROID ES INHALADOS MAS AGONISTAS DE ƒÀ2 DE ACCION PROLONGADA (STRATOS 1).
Investigador Principal: ALFREDO DE DIEGO DAMIÁ
D2210C00007
EVALUACIÓN DEL IMPACTO FARMACOECONÓMICO DEL USO DE OMALIZUMAB EN EL ASMA GRAVE EN PRÁCTICA CLÍNICA HABITUAL EN LA COMUNIDAD VALENCIANA.
Investigador Principal: ALFREDO DE DIEGO DAMIÁ
FIS-OMA-2014-01